Filing Details
- Accession Number:
- 0001127602-25-002522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-30 17:57:00
- Reporting Period:
- 2024-06-10
- Accepted Time:
- 2025-01-30 17:57:00
- SEC Url:
- Form 4 Filing
Issuer
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2017499 | Mandy Glew | 9200 W. 108Th Circle Westminster CO 80021 | Svp And President, Emea | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-06-10 | 563 | $68.15 | 3,563 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-01-28 | 1,148 | $0.00 | 4,711 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | A | Direct |
Footnotes
- The price reported reflects the U.S. Dollar equivalent of the purchase price. The shares were purchased in a single transaction for the price of ?53.4751. The reporting person will, upon request, provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The Human Resources Committee determined on 01/28/2025 the achievement of the performance factors for the performance contingent restricted stock units granted on January 26, 2022 (574 of which were previously reported in Table II of Form 4), and the shares will vest on January 31, 2025, subject to continued employment.
- Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
- The reported transaction involved the award of performance contingent restricted stock units. The reporting person has previously reported awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes all of the restricted stock units awarded to the Reporting Person, including performance contingent restricted stock units for which performance has been determined.